Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets)

This study has been completed.
Information provided by (Responsible Party):
LG Life Sciences Identifier:
First received: November 30, 2012
Last updated: October 22, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)